4//SEC Filing
Sussman Joel F. 4
Accession 0000899243-20-002872
CIK 0001563577other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 6:05 PM ET
Size
5.3 KB
Accession
0000899243-20-002872
Insider Transaction Report
Form 4
Sussman Joel F.
Chief Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-01-31+49,263→ 49,623 totalExercise: $14.84Exp: 2030-01-30→ Common Stock (49,623 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a four year period commencing January 31, 2020.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001774297
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 6:05 PM ET
- Size
- 5.3 KB